文献速递真菌感染艾滋病与性传播感染医院感染防控

法国需ICU入院的隐球菌病表现与预后:CRYPTO-ICU研究

Presentation and Prognosis of Cryptococcosis Requiring Intensive Care Unit Admission in France: The CRYPTO-ICU Study.
PubMed 文献 · Clin Infect Dis · 2026-01-01

该回顾性多中心研究纳入2000—2022年法国30个ICU收治的151例重症隐球菌病患者,56.9%为HIV感染者,非HIV病例随时间增多。90天死亡率为49.6%,SOFA评分、2000—2012年入院、播散性感染及ICU前启动抗真菌治疗与90天死亡率独立相关,HIV血清状态则无关。

要点

  • 重症隐球菌病ICU患者90天死亡率达49.6%,需机械通气联合血管活性药物者死亡率极高。
  • 非HIV患者比例随时间上升,2012—2022年为51.3%,其中82.5%接受免疫抑制治疗。
  • ICU前启动抗真菌治疗与更低90天死亡率独立相关(aHR 0.38)。

核心结论

  • 需ICU入院的重症隐球菌病累及越来越多非HIV患者,死亡率高但呈下降趋势。
  • 早期诊断和治疗对改善预后至关重要。

研究设计与样本

  • 回顾性、多中心研究,纳入2000—2022年法国30个ICU收治的151例重症隐球菌病患者。

主要发现

  • 56.9%为HIV感染者;非HIV病例比例从2012年前的32.4%升至2012—2022年的51.3%。
  • 中枢神经系统感染占91.1%,肺部感染占39.7%,真菌血症占59.8%,播散性感染占75.2%。
  • 入ICU时神经衰竭占75.5%,呼吸衰竭占47.7%,急性肾损伤占41.7%,休克占24.5%。
  • 90天死亡率49.6%;需机械通气联合血管活性药物者90天死亡达94%,仅机械通气者为38.7%,无需器官支持者为17.2%(P < .001)。

关键数值与推荐

  • SOFA评分与90天死亡率独立相关(aHR 1.04,95%CI 1.02-1.06)。
  • 2000—2012年入院与90天死亡率独立相关(aHR 2.30,95%CI 1.36-3.89)。
  • 播散性感染与90天死亡率独立相关(aHR 2.32,95%CI 1.15-4.67)。

临床怎么用

  • 对重症隐球菌病应尽早启动抗真菌治疗,不必等待ICU入住。
  • 需ICU器官支持(机械通气、血管活性药物、肾脏替代治疗)者死亡风险极高,应积极评估与干预。
  • 非HIV但接受免疫抑制治疗的患者也应纳入隐球菌病鉴别诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cryptococcus causes life-threatening opportunistic infections in immunocompromised hosts. Data on the most severe cases requiring intensive care unit (ICU) admission remain limited. METHODS: We conducted a retrospective, multicenter study of patients admitted to 30 French ICUs for severe cryptococcosis between 2000 and 2022. RESULTS: Among 151 patients included, 56.9% were patients with human immunodeficiency virus (HIV). Cases in patients without HIV became increasingly prevalent over time (51.3% in 2012-2022 vs 32.4% before 2012); 82.5% were receiving immunosuppressive therapy. Central nervous system infection was predominant (91.1%), followed by lung infection (39.7%). Fungemia occurred in 59.8% patients, and 75.2% had disseminated infection. Neurological failure was the leading organ impairment at admission (75.5%) followed by respiratory failure (47.7%), acute kidney injury (41.7%), and shock (24.5%). The median Sequential Organ Failure Assessment (SOFA) score was 4 (interquartile range, 2-7). Invasive mechanical ventilation, vasopressors, and renal replacement therapy were required in 54.9%, 34.4%, and 18.5% of patients, respectively. At day 90, 94% of patients requiring mechanical ventilation and vasopressors were deceased, compared to 38.7% with invasive ventilation alone and 17.2% without any organ support (P < .001). Overall, 90-day mortality reached 49.6%. SOFA score (adjusted hazard ratio [aHR], 1.04 [95% confidence interval [CI], 1.02-1.06]), admission between 2000 and 2012 (aHR, 2.30 [95% CI, 1.36-3.89]), disseminated infection (aHR, 2.32 [95% CI, 1.15-4.67]), and initiation of antifungal therapy before ICU admission (aHR, 0.38 [95% CI, .22-.63]) were independently associated with 90-day mortality, whereas HIV serostatus was not (aHR, 0.93 [95% CI, .47-1.84]). CONCLUSIONS: Severe cryptococcosis requiring ICU admission affects an increasing number of patients without HIV and is associated with high, though declining, mortality. Early diagnosis and treatment are mandatory to improve prognosis.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Herbel S, Paccoud O, de Montmollin É, et al. Presentation and Prognosis of Cryptococcosis Requiring Intensive Care Unit Admission in France: The CRYPTO-ICU Study. Clin Infect Dis. 2026. PMID: 41715985. doi:10.1093/cid/ciag091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。